These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3999084)

  • 21. Clinical comparison of terbutaline and isoprenaline administered by inhalation. A double-blind study.
    Huhti E
    Ann Clin Res; 1972 Jun; 4(3):152-64. PubMed ID: 4556938
    [No Abstract]   [Full Text] [Related]  

  • 22. Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response.
    Rich S; Martinez J; Lam W; Levy PS; Rosen KM
    Am Heart J; 1983 Jan; 105(1):119-27. PubMed ID: 6849224
    [No Abstract]   [Full Text] [Related]  

  • 23. Assessment of orciprenaline and isoproterenol infusions in asthmatic patients.
    McEvoy JD; Vall-Spinosa A; Paterson JW
    Am Rev Respir Dis; 1973 Sep; 108(3):490-500. PubMed ID: 4745246
    [No Abstract]   [Full Text] [Related]  

  • 24. Nifedipine, a new antihypertensive with rapid action.
    Guazzi M; Olivari MT; Polese A; Fiorentini C; Magrini F; Moruzzi P
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):528-32. PubMed ID: 913018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced survival after isoprenaline/dopamine in d,l-propranolol intoxicated rats.
    Toet AE; te Biesebeek JD; Vleeming W; Wemer J; Meulenbelt J; de Wildt DJ
    Hum Exp Toxicol; 1996 Feb; 15(2):120-8. PubMed ID: 8645502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of thalidomide on isoprenaline-induced acute myocardial injury: a haemodynamic, histopathological and ultrastructural study.
    Loh HK; Sahoo KC; Kishore K; Ray R; Nag TC; Kumari S; Arya DS
    Basic Clin Pharmacol Toxicol; 2007 Apr; 100(4):233-9. PubMed ID: 17371527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of isoproterenol on the first derivative of the carotid pulse-wave in healthy subjects and in cardiac patients.
    Simonyi J; Décsy J; Herpai Z
    Cor Vasa; 1970; 12(1):38-49. PubMed ID: 5446025
    [No Abstract]   [Full Text] [Related]  

  • 28. Oral hydralazine therapy for primary pulmonary hypertension.
    Rubin LJ; Peter RH
    N Engl J Med; 1980 Jan; 302(2):69-73. PubMed ID: 7350435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Primary pulmonary arterial hypertension. Trial treatment with nifedipine, diazoxide and isoproterenol].
    Thomas D; Drobinski G; Komajda M; Grosgogeat Y
    Nouv Presse Med; 1980 Dec; 9(48):3698-9. PubMed ID: 7454591
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of cardiorespiratory effects of isoprenaline and salbutamol in patients with bronchial asthma.
    Warrell DA; Robertson DG; Howes JN; Conolly ME; Paterson JW; Beilin LJ; Dollery CT
    Br Med J; 1970 Jan; 1(5688):65-70. PubMed ID: 5411446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of canine pulmonary hypertension: effects of norepinephrine and isoproterenol on pulmonary vascular pressure-flow characteristics.
    Ducas J; Duval D; Dasilva H; Boiteau P; Prewitt RM
    Circulation; 1987 Jan; 75(1):235-42. PubMed ID: 3791605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Propranolol treatment in children with tetralogy of Fallot alters the response to isoprenaline after surgical repair.
    Barazzone C; Jaccard C; Berner M; Dayer P; Rouge JC; Oberhansli I; Friedli B
    Br Heart J; 1988 Aug; 60(2):156-61. PubMed ID: 3415875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isoproterenol in pulmonary hypertension.
    Pelman MJ; Tiep BL; Westinghouse WD
    N Engl J Med; 1978 Jan; 298(1):51-2. PubMed ID: 618453
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of body temperature on cardiotoxicity of isoprenaline in rats.
    Harri MN
    Acta Pharmacol Toxicol (Copenh); 1976 Aug; 39(2):214-24. PubMed ID: 947298
    [No Abstract]   [Full Text] [Related]  

  • 35. Vasodilators and prostaglandin inhibitors in primary pulmonary hypertension.
    Hermiller JB; Bambach D; Thompson MJ; Huss P; Fontana ME; Magorien RD; Unverferth DV; Leier CV
    Ann Intern Med; 1982 Oct; 97(4):480-9. PubMed ID: 7125407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pulmonary hypertension in chronic obstructive lung disease. Hemodynamic changes induced by oxygen, verapamil, and isoproterenol acute administration (author's transl)].
    Sclavo M; Bucca C; Rolla G; Borello G; Balbi L; Angelino PF
    G Ital Cardiol; 1981; 11(5):634-42. PubMed ID: 7286534
    [No Abstract]   [Full Text] [Related]  

  • 37. The bronchodilator effect of salbutamol administered by IPPB to patients with asthma. A controlled comparison with isoproterenol and placebo.
    Spitzer SA; Goldschmidt Z; Dubrawsky C
    Chest; 1972 Sep; 62(3):273-6. PubMed ID: 4403473
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparison between isoprenaline infusions and bolus injections to assess beta-adrenoceptor function in man, with special reference to cardiac contractility and the influence of autonomic reflexes.
    Martinsson A; Melcher A; Lindvall K; Hjemdahl P
    Acta Physiol Scand; 1991 Feb; 141(2):167-80. PubMed ID: 1646559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative trial of salbutamol and isoprenaline in asthma.
    Poppius H; Leinonen L; Muittari A
    Ann Clin Res; 1974 Apr; 6(2):126-8. PubMed ID: 4837885
    [No Abstract]   [Full Text] [Related]  

  • 40. [Hemodynamic effects of aminophylline in primary pulmonary hypertension].
    Klein W
    Wien Klin Wochenschr; 1969 Sep; 81(37):651-3. PubMed ID: 5351160
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.